<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Quantified Alternative Investment Fund Quantified Alternative Investment Fund Investor Class Shares — News on 6ix</title>
<link>https://6ix.com/company/quantified-alternative-investment-fund-quantified-alternative-investment-fund-investor-class-shares</link>
<description>Latest news and press releases for Quantified Alternative Investment Fund Quantified Alternative Investment Fund Investor Class Shares on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Mon, 20 Apr 2026 04:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/quantified-alternative-investment-fund-quantified-alternative-investment-fund-investor-class-shares" rel="self" type="application/rss+xml" />
<item>
<title>Raytech Holding Limited Announces Strategic Expansion into Personal Health Care Electronics Services; Strengthens Leadership by Appointing Mr. Haoyuan Liu as Chairman and Executive Director</title>
<link>https://6ix.com/company/quantified-alternative-investment-fund-quantified-alternative-investment-fund-investor-class-shares/news/raytech-holding-limited-announces-strategic-expansion-into-personal-health-care-electronics-services-strengthens-leadership-by-appointing-mr-haoyuan-liu-as-chairman-and-executive-director-22</link>
<guid isPermaLink="true">https://6ix.com/company/quantified-alternative-investment-fund-quantified-alternative-investment-fund-investor-class-shares/news/raytech-holding-limited-announces-strategic-expansion-into-personal-health-care-electronics-services-strengthens-leadership-by-appointing-mr-haoyuan-liu-as-chairman-and-executive-director-22</guid>
<pubDate>Mon, 20 Apr 2026 04:00:00 GMT</pubDate>
<description>HONG KONG, April 20, 2026 (GLOBE NEWSWIRE) -- Raytech Holding Limited (NASDAQ: RAY) (“RAY” or the “Company”) today announced a strategic expansion of its</description>
</item>
<item>
<title>Onto Innovation Announces Strategic Partnership With Leading X-Ray Provider Rigaku To Advance Next-Generation Process Control Solutions</title>
<link>https://6ix.com/company/quantified-alternative-investment-fund-quantified-alternative-investment-fund-investor-class-shares/news/onto-innovation-announces-strategic-partnership-with-leading-x-ray-provider-rigaku-to-advance-next-generation-process-control-solutions-46</link>
<guid isPermaLink="true">https://6ix.com/company/quantified-alternative-investment-fund-quantified-alternative-investment-fund-investor-class-shares/news/onto-innovation-announces-strategic-partnership-with-leading-x-ray-provider-rigaku-to-advance-next-generation-process-control-solutions-46</guid>
<pubDate>Mon, 20 Apr 2026 04:00:00 GMT</pubDate>
<description>Systems delivered for advanced V-NAND and DRAM metrology, with expanding engagement across top-tier logic and memory customers WILMINGTON, Mass.--(BUSINESS</description>
</item>
<item>
<title>Purepoint Uranium Announces Grant of Restricted Share Units</title>
<link>https://6ix.com/company/quantified-alternative-investment-fund-quantified-alternative-investment-fund-investor-class-shares/news/purepoint-uranium-announces-grant-of-restricted-share-units-13</link>
<guid isPermaLink="true">https://6ix.com/company/quantified-alternative-investment-fund-quantified-alternative-investment-fund-investor-class-shares/news/purepoint-uranium-announces-grant-of-restricted-share-units-13</guid>
<pubDate>Mon, 20 Apr 2026 04:00:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - April 20, 2026) - Purepoint Uranium Group Inc. (TSXV: PTU) (OTCQB: PTUUF) ("Purepoint" or the "Company") approved the</description>
</item>
<item>
<title>CVRx Announces Nomination of Michael Dale for Election to the Board of Directors</title>
<link>https://6ix.com/company/quantified-alternative-investment-fund-quantified-alternative-investment-fund-investor-class-shares/news/cvrx-announces-nomination-of-michael-dale-for-election-to-the-board-of-directors-9</link>
<guid isPermaLink="true">https://6ix.com/company/quantified-alternative-investment-fund-quantified-alternative-investment-fund-investor-class-shares/news/cvrx-announces-nomination-of-michael-dale-for-election-to-the-board-of-directors-9</guid>
<pubDate>Mon, 20 Apr 2026 04:00:00 GMT</pubDate>
<description>MINNEAPOLIS, April 20, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX), a medical device company focused on developing, manufacturing and commercializing</description>
</item>
<item>
<title>Via Renewables Announces a Redemption of 209,437 Shares of Its 8.75% Series a Fixed-To-Floating Rate Cumulative Redeemable Perpetual Preferred Stock</title>
<link>https://6ix.com/company/quantified-alternative-investment-fund-quantified-alternative-investment-fund-investor-class-shares/news/via-renewables-announces-a-redemption-of-209437-shares-of-its-875percent-series-a-fixed-to-floating-rate-cumulative-redeemable-perpetual-preferred-stock-66</link>
<guid isPermaLink="true">https://6ix.com/company/quantified-alternative-investment-fund-quantified-alternative-investment-fund-investor-class-shares/news/via-renewables-announces-a-redemption-of-209437-shares-of-its-875percent-series-a-fixed-to-floating-rate-cumulative-redeemable-perpetual-preferred-stock-66</guid>
<pubDate>Mon, 20 Apr 2026 04:00:00 GMT</pubDate>
<description>HOUSTON, TX / ACCESS Newswire / April 20, 2026 / Via Renewables, Inc. ("Via Renewables" or the "Company") (NASDAQ:VIASP), an independent retail energy</description>
</item>
<item>
<title>Kailera Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares</title>
<link>https://6ix.com/company/quantified-alternative-investment-fund-quantified-alternative-investment-fund-investor-class-shares/news/kailera-announces-closing-of-initial-public-offering-and-full-exercise-of-underwriters-option-to-purchase-additional-shares-5</link>
<guid isPermaLink="true">https://6ix.com/company/quantified-alternative-investment-fund-quantified-alternative-investment-fund-investor-class-shares/news/kailera-announces-closing-of-initial-public-offering-and-full-exercise-of-underwriters-option-to-purchase-additional-shares-5</guid>
<pubDate>Mon, 20 Apr 2026 04:00:00 GMT</pubDate>
<description>WALTHAM, Mass., April 20, 2026 (GLOBE NEWSWIRE) -- Kailera Therapeutics, Inc. (Nasdaq: KLRA) (Kailera), an advanced clinical-stage biotechnology company</description>
</item>
</channel>
</rss>